Decreased expression of MT1E is a potential biomarker of prostate cancer progression

Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR) of the disease. Microarray-based gene expression profil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Demidenko, Rita, Daniunaite, Kristina, Bakavicius, Arnas, Sabaliauskaite, Rasa, Skeberdyte, Aiste, Petroska, Donatas, Laurinavicius, Arvydas, Jankevicius, Feliksas, Lazutka, Juozas R., Jarmalaite, Sonata
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617458/
https://ncbi.nlm.nih.gov/pubmed/28977898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18683
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares